APA (7th ed.) Citation

Ma, W., Shi, Q., Su, X., Zhang, L., Chen, C., Zhang, C., & Wang, Y. (2025). Carcinoembryonic antigen as a predictor of treatment outcomes in cancer patients receiving immune checkpoint inhibitors. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Ma, Wangbin, Qiao Shi, Xiaozhe Su, Lilong Zhang, Chen Chen, Chao Zhang, and Ying Wang. Carcinoembryonic Antigen as a Predictor of Treatment Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors. Taylor & Francis Group, 2025.

MLA (9th ed.) Citation

Ma, Wangbin, et al. Carcinoembryonic Antigen as a Predictor of Treatment Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors. Taylor & Francis Group, 2025.